Manufacturing could be revolutionized by synthetic biology

biolog

The emerging discipline of synthetic biology sits at the crux of the intersection between design, biology, computing and manufacturing…[I]t appears more and more probable that we are on the cusp of a paradigm shift, where…biology is adopted as the next big manufacturing technology.

[The objective of Ginkgo Bioworks, an “organism design” company,] is to take synthetic biology techniques to an industrial level, machine-injecting DNA sequences into baker’s yeast creating “living organism” products like perfumes, sweeteners, cosmetics and other things that are typically extracted from plants.

There are two main potential benefits from the technology. Replacing consumption of finite natural resources with lab-grown alternatives, and the potential to replicate actual genes to produce authentic fragrances replacing chemical synthetic scented products that currently dominate the marketplace.

Genetic modification and DNA sequencing has traditionally been shrouded by a lack of transparency and questions around health and safety, though…it is worth noting that health concerns around food and various other consumer products are not exclusive to genetically modified products. Still, clearly overcoming the attached societal stigma remains a challenge for synthetic biology startups and researchers alike.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: Why Biology Holds the Key to the Future of Design and Manufacturing

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Picture1-5
Science Disinformation Gap: The transatlantic battle over social media and censorship
ChatGPT Image May 10, 2026, 08_16_59 PM 2
Overmedicalization? RFK Jr.’s antidepressant crackdown raises conflict questions over his fee stake in Wisner Baum, the tort firm built on suing drug makers
Picture1-1
Cooling the planet with balloons: Could a geoengineering gamble slow global warming?
Screenshot-2026-05-12-at-9.58.31-PM
'He seems fine': Marty Makary out as FDA commissioner
ChatGPT-Image-May-12-2026-08_39_41-PM
GLP podcast: Big Pharma, Big Ag, Big Food—health harming industries or life-saving innovators?
Screenshot-2026-05-11-104424
Hantavirus outbreak research: Trump administration shut down study last year on rodent-to-human transmission
Screenshot 2026-05-11 at 11.30
Despite politicized disinformation, Midwest AI data centers are fueling a solar energy boom
Screenshot-2026-04-23-at-11.00.36-AM
Regulators' dilemma: Thalidomide, Metformin, and the cost of getting drug approvals wrong
Picture1-14
When superbugs threaten vulnerable children: Can AI help solve antibiotic resistance?
Screenshot-2026-04-12-135256
Bixonimania: The fake disease scam that AI swallowed whole
Screenshot-2026-05-12-at-10.05.11-AM
Pro-vaccine “hero” vs. an anti-vax “villain”: ‘Bad Vaxx’ video stirs MAHA backlash
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.